</>Build with Tariff Intelligence|Programmatic access to tariff calculations and HS code classification.Explore Developer Resources →
3002.15.00/Novavax COVID-19 Vaccine Adjuvanted/Canada

Novavax COVID-19 Vaccine Adjuvanted from Canada

Novavax protein-based COVID-19 vaccine with Matrix-M adjuvant, in pre-filled syringes for measured retail doses. Classified as immunological product HTS 3002.15.00.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.05.860%Universal product exemption (U.S. note 52(b))
Calculate with your customs valueVerify classification with AI

Import Tips

• Saponin adjuvant certificates; hypersensitivity warnings

• 2-8°C storage; 30-day room temp stability post-thaw

• Bulk protein antigen as 3002.30 without adjuvant

Novavax COVID-19 Vaccine Adjuvanted from Canada — Import Duty Rate | HTS 3002.15.00